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The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) has several distinct biochemical
activities, including initiation of RNA synthesis by a de novo mechanism, extension from a primed template,
nontemplated nucleotide addition, and synthesis of a recombinant RNA product from two or more nonco-
valently linked templates (template switch). All of these activities require specific interaction with nucleoside
triphosphates (NTPs). Based on the structure of the HCV RdRp bound to NTP (S. Bressanelli, L. Tomei, F. A.
Rey, and R. DeFrancesco, J. Virol. 76:3482–3492, 2002), we mutated the amino acid residues that contact the
putative initiation GTP and examined the effects on the various activities. Although all mutations retained the
ability for primer extension, alanine substitution at R48, R158, R386, R394, or D225 decreased de novo
initiation, and two or more mutations abolished de novo initiation. While the prototype enzyme had a Km for
GTP of 3.5 M, all of the mutations except one had Kms that were three- to sevenfold higher. These results
demonstrate that the affected residues are functionally required to interact with the initiation nucleotide.
Unexpectedly, many of the mutations also affected the addition of nontemplated nucleotide, indicating that
residues in the initiating NTP (NTPi)-binding pocket are required for nontemplated nucleotide additions.
Interestingly, mutations in D225 are dramatically affected in template switch, indicating that this residue of the
NTPi pocket also interacts with components in the elongation complex. We also examined the interaction of
ribavirin triphosphate with the NTPi-binding site.
Hepatitis C Virus (HCV), a member of the flaviviridae family
of positive-strand RNA viruses, infects up to 3% of the world’s
population (1). A prime target for antiviral treatment in HCV
is the NS5B protein, the RNA-dependent RNA polymerase
(RdRp) responsible for viral RNA synthesis. The RdRp is one
of the subunits expected to participate in HCV replication and
is responsible for the initiation and elongation of viral RNA
synthesis. Initiation of RNA synthesis in infected cells likely
starts de novo; that is, by use of a 1-nucleotide (nt) primer (3,
14). This mode of RNA synthesis requires a specialized site in
the RdRp, called the I site, that specifically recognizes the
initiating nucleoside triphosphate (designated NTPi, with GTP
being preferred by the recombinant HCV RdRp) (14, 23, 25).
A second NTP-binding pocket, the I  1 site, binds a nucleo-
tide for phosphoryl transfer as dictated by the template base
(14). Cocrystal structures of the HCV RdRp and nucleotides
have been reported previously (3, 21), identifying a number of
residues at D225, R48, R158, R386, R394, and S367 that in-
teract with specific moieties of the initiation GTP (Fig. 1A). In
this structure, it is not known whether the GTP binds to the I
site or the I  1 site. NTPi binding to the I site is base specific,
while binding of the second NTP to the I  1 site should be
directed by the template (25). Because the RdRp-GTP struc-
ture was determined without a template, it is likely that the
residues identified recognized the NTPi.
Despite evidence that de novo initiation is the most relevant
mechanism for HCV RNA synthesis in cells, a version of the
HCV NS5B named 21, which lacks the C-terminal 21 hydro-
phobic residues, has at least three additional activities related
to nucleotide polymerization: primer extension, nontemplated
nucleotide addition to the 3 terminus of the RNA, and the
ability to synthesize one RNA product from two or more non-
covalently linked templates (Fig. 1B). For clarity, we shall call
the latter process template switch. Nontemplated nucleotide
addition, de novo initiation, and template switch by the HCV
RdRp occur at lower levels in reactions lacking Mn2, but
these activities are greatly increased when up to 2 mM Mn2 is
added to the reaction (16, 25). To date, the functional coordi-
nation between these activities has not been carefully exam-
ined.
We have characterized various activities of the HCV RdRp
by using a 19-nt template, named LE19, derived from the 3
end of the minus-strand RNA of bovine viral diarrhea virus
(BVDV). LE19 is predicted to form a simple stem-loop with an
unpaired 3-nt initiation sequence at the 3 end that directs
initiation (Fig. 1B). A similar, but more stable, structure is also
found at the 3 end of the minus-strand HCV RNA (15, 26).
Several of the products produced by 21 with LE19 were
previously characterized (23, 25). De novo initiation generates
a 19-nt product that is initiated from a 3-terminal cytidylate.
LE19 could also partially anneal as a dimer and be extended to
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form a 32-nt product (Fig. 1C). Other products included ones
with additional nucleotide(s) at the 3 end of LE19 and tem-
plate switch products of 38 nt and longer that are thought to be
multimeric forms of the 19-nt product. In this work we made
mutations in recombinant HCV NS5B that are predicted to
affect the I site and characterized the different modes of RNA
synthesis in vitro by primarily using LE19. We found that some
mutations that affected interaction with the NTPi could differ-
entially alter the various activities of the HCV RdRp.
MATERIALS AND METHODS
Purification of NS5B from Escherichia coli. NS5B proteins were expressed
from pET plasmid derivatives in E. coli BL21(DE3). The prototype HCV NS5B
protein lacked the hydrophobic C-terminal 21 amino acids. Six histidines were
FIG. 1. Mutations within the catalytic pocket of the HCV RdRp and assays for activities of the HCV RdRp. (A) Locations of the mutations
in the HCV RdRp and their proposed function in interacting with the initiation GTP. The two stars representing D318, D319, and D220 denote
the location of the site for nucleotide polymerization. (B) The modes of RNA synthesis that are directed by RNA LE19. A monomer of LE19 could
direct de novo initiation from the 3-most cytidylate, producing a 19-nt product. In the event that two LE19 molecules base pair with sequences
at their 3 ends, the resultant heterodimer could direct the synthesis of a 32-nt primer extension product which, based on the sequence, could be
generated in the absence of GTP. Should the ternary complex translocate from one template to another without release of the nascent RNA, a
process called template switch, a product of 38 nt is generated. (C) Demonstration of the products from LE19 template by the prototype HCV
RdRp, 21, and one with mutations at the active site. GTP is needed for de novo initiation, resulting in 19-nt RNA and 38-nt template switch
products generated after de novo initiation. GTP is not needed to produce a primer extension product of 32- and 20-nt nontemplated nucleotide
addition to LE19. The sizes of the products have been previously characterized (22, 23, 25). (D) Preparation of recombinant proteins used in this
study. The proteins were separated by sodium dodecyl sulfate-polyacrylamide electrophoresis (4 to 12% polyacrylamide) and were stained with
Coomassie blue. The names of the mutant proteins are derived from the respective amino acid, the position along the NS5B polypeptide, and the
final amino acid at that position.
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added to the C termini of each of the proteins to allow affinity purification.
Bacteria were grown at 30°C in standard Luria-Bertani medium supplemented
with 50 g of ampicillin/ml and 34 g of chloramphenicol/ml until the culture
reached an optical density at 600 nm of 1.0. The culture temperature was then
lowered to 25°C, and expression was induced for 4 h with 1 mM isopropyl-
thiogalactoside. Cells were harvested after centrifugation, and recombinant
RdRp from HCV was purified in buffer lacking divalent metals by passage
through a Talon nickel affinity column (Invitrogen Inc.) followed by a poly(U)-
agarose column (Pharmacia Inc). The protein was adjusted to between 1 and 2
mg/ml after quantification by the Lowry assay, with bovine serum albumin as a
concentration control.
Site-directed mutagenesis of the HCV NS5B cDNA was made by using the
QuickChange kit (Stratagene, San Diego, Calif.) according to the manufacturer’s
protocol. The entire cDNA was then sequenced to confirm that the specified
mutation was made and that no additional changes had inadvertently taken
place. The mutant plasmids were transformed into E. coli BL21(DE3), induced
for expression, and purified as described above for 21.
RdRp activity assays. RNAs were chemically synthesized by Dharmacon, Inc.
(Boulder, Colo.), and were purified by denaturing gel electrophoresis, checked
for quality by toluidine blue staining, and quantified by spectrophotometry.
Standard RdRp assays consisted of 0.125 M template with 0.08 M NS5B in a
20-l reaction mixture containing 20 mM sodium glutamate (pH 8.2), 4 mM
MgCl2, 12.5 mM dithiothreitol, 0.5% (vol/vol) Triton X-100, 200 M each ATP
and UTP, and 250 nM [-P32]CTP (Amersham, Inc.). GTP was used at a final
concentration of 200 M unless stated otherwise. For titrations with GTP ana-
logs, no GTP was added to the reaction mix, because LE19 used GTP only for
initiation. Where present, MnCl2 was added to a final concentration of 1 mM.
Modifications to the reaction mixtures will be noted as appropriate. The final
reaction mixture contained 10 mM NaCl that derived from the RdRp storage
buffer. RNA synthesis reaction mixtures were incubated at 25°C for 60 min (a
time at which RNA synthesis was in the linear phase for all of the mutant
proteins) and was stopped by phenol-chloroform extraction followed by ethanol
precipitation in the presence of 5 g of glycogen and 0.5 M ammonium acetate.
Time course analyses used a master reaction mixture. Aliquots of the reaction
mixtures were sampled at 0-, 5-, 10-, 15-, 20-, 30-, 45-, 60-, and 90-min time
intervals and were terminated for RNA synthesis by the addition of an equal
volume of electrophoresis dye mixture containing 95% formamide. Products
were usually separated by electrophoresis on denaturing (7.5 M urea) polyacryl-
amide gels. Gels were wrapped in plastic and exposed to film at 80°C. Each
result shown was reproduced in at least one and usually two to four independent
experiments. Quantification of radiolabeled bands was performed with a Phos-
phorImager (Molecular Dynamics).
The kinetic constant, Km, for the initiation GTP was determined as previously
described by Ranjith-Kumar et al. (25). To prevent reinitiation and thereby
determine the initial reaction rates, heparin (to 0.5 mg/ml) and 50 M nonra-
diolabeled CTP was added to the reaction mixture after 10 min of incubation.
Mn2 was present at 1 mM. The reaction products were quantified and plotted
using Microsoft Excel, and the Km values were determined from the X intercept.
RESULTS
In an attempt to better understand the mechanism of de
novo initiation by viral RdRps, we used the HCV RdRp, 21,
as the prototype to construct a series of mutant proteins with
one or more alanine substitutions in the putative NTPi site
(Fig. 1A). All proteins were purified by use of a metal affinity
column followed by a poly(U) column, resulting in greater than
98% purity (Fig. 1D). No obvious differences in either the
expression of the mutant proteins or their purification were
apparent (data not shown). For nomenclature, the mutant
proteins were named by the mutated amino acid followed by
the identity of the final mutation. Where more than one amino
acid was changed, the protein was named by all of the muta-
tions.
To determine whether the residues identified by Bressanelli
et al. (3) affected the I or the I  1 pocket, we initially exam-
ined the effects of these mutations using LE19 as the template
(Fig. 2). RNA synthesis conditions, such as the use of Mn2,
the concentration of template, NTPs, etc., were previously
optimized and used as described in Ranjith-Kumar et al. (23–
25). In the absence of Mn2, all of the mutant proteins except
S367A lost the ability to initiate RNA synthesis by the de novo
mechanism (Fig. 2). In contrast, only protein R158A showed
significantly less ability to extend from a primer (Fig. 2). These
results indicate that most of the mutated residues do affect
interaction with the NTPi. Additional evidence consistent with
this claim is presented below (for example, see Fig. 3A). For
the remainder of this work, we will refer to these residues as
affecting interaction with the NTPi.
All proteins were examined for the activities attributed to
the HCV RdRp. The reactions were performed in the presence
and absence of GTP, which was required for de novo initiation
(25), and with and without Mn2 at 1 mM, which significantly
increases de novo initiation, primer extension, and nontem-
plated nucleotide addition (22, 25). Mutant S367A, which pu-
tatively affects H bonding to the  phosphate, had activities
similar to those of 21 (Fig. 2, lanes 29 to 32). Activities of the
other mutant proteins were dependent on the divalent metal(s)
present in the reaction (Fig. 2). In the presence of only Mg2,
R158A was severely affected for all four activities of 21. All
other single-amino-acid mutants were active for primer exten-
sion to various degrees, ranging from levels comparable to
those of 21 (as in D225A) to reduced levels (e.g., R386A and
R48A). To examine the effect on primer extension in the ab-
sence of Mn2 further, we tested double mutants R158A/
R386A and R158A/R394A. These two mutant proteins did not
produce the 32-nt product (compare lanes 25 to 26 with 33 to
34 and 37 to 38). Together, these results suggest that residues
that bind the NTPi can participate in other reactions that
follow the initial RNA synthesis.
Activities of the mutant proteins were quite different in the
presence of Mn2. D225A, which putatively forms an H bond
with the ribose 2 OH of the NTP, was unaffected for de novo
initiation when assayed at 60 min after the initiation of RNA
synthesis. Other single-amino-acid changes had reduced, albeit
detectable, amounts of de novo initiation products (Fig. 2,
lanes 1 to 32). Proteins R158A/R386A, R158A/R394A, and
R158A/R367A/R386A eliminated de novo initiation product
even in the presence of Mn2 but were capable of primer
extension (Fig. 2, lanes 33 to 44). These results suggest that
Mn2 likely helps to stabilize the interaction between the ac-
tive site and the NTPi. This activity will be characterized fur-
ther with oligonucleotide mimics of the NTPi.
An activity associated with NTPi binding is the inhibition of
primer extension (24). GTP is postulated to inhibit primer
extension in a Mn2-independent manner that requires the
C-terminal tail and the active-site  loop. This effect is seen by
the ca. three- to fivefold difference in the amount of the 32-nt
RNA in the presence of GTP (Fig. 2, lanes 1 and 2). In the
absence of Mn2 only S367A had different levels of the 32 mer
if GTP was present. These results are consistent with the
model proposed in Ranjith-Kumar et al. (24), in that shutoff of
primer extension requires the residues that bind the NTPi.
Template switch was also affected by the amino acid substi-
tutions in the presence of Mn2. As expected, several of the
mutations that reduced de novo initiation also reduced the
amount of the 38 mer. However, D225A, which is capable of
robust de novo initiation in the presence of Mn2, unexpect-
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edly produced reduced amounts of product of 38 nt and longer
that arose from template switch (Fig. 2, lanes 17 to 20, and data
not shown). Hence, D225 may also have a role in interacting
with the template or the nascent RNA. Lastly, mutations in the
NTPi-binding site also affected TNTase activity of the HCV
RdRp. A 21-nt product generated by nontemplated nucleotide
addition was clearly observed with 21 (Fig. 2, lanes 1, 2, 25,
and 26) but was significantly reduced with mutations in the
NTPi-binding residues.
This survey of the products made from LE19 by 21 and the
NTPi mutants clearly indicates that, while the mutated resi-
dues affect interaction with the NTPi, different activities of the
HCV RdRp can be intricately linked. To understand the func-
tion of these residues better, we will expand the examination of
their roles in de novo initiation, TNTase activity, and template
switch in the following sections.
De novo initiation. To confirm that the mutations caused a
defect in de novo initiation, we used LE19P, a chemically
synthesized RNA identical to LE19, except with an additional
3 puromycin. This modification renders the template incapa-
ble of nontemplated nucleotide addition but allows de novo
initiation (22). In the absence of Mn2, 21 and S367A pro-
duced detectable and comparable amounts of the de novo-
initiated 19 mer (Fig. 3A, top panel, lanes 1 and 3). However,
none of the other mutations produced detectable amounts of
the 19 mer. In the presence of Mn2, all single-amino-acid
substitution proteins produced the 19 mer at levels comparable
to those of 21, except for D225A, which increased de novo
initiation by 30%, and R394A, which decreased it by 77%. We
then tested proteins with two or three mutations and found
that, similar to results with LE19, de novo initiation was fur-
ther decreased by combining two or more amino acid substi-
tutions that affect NTPi binding (Fig. 3A, lower panel, lanes 9
to 11). An effect was also observed on the production of the
38-nt template switch product, except for D225A, which pro-
duces significantly less of this product (Fig. 3A, lane 7). These
defects in de novo initiation with LE19P were less obvious than
with LE19 (compare Fig. 3, bottom panel, to Fig. 2), likely due
to puromycin providing additional contacts for the HCV RdRp
or puromycin blocking primer extension activity and increasing
the frequency of de novo initiation.
To examine whether there is an effect on the kinetics of
RNA synthesis, we compared the synthesis of the 19-nt RNA
over time by 21 and two mutants, R386A and D225A. In the
presence of Mn2, all the proteins showed an increase in RNA
synthesis with time up to 90 min, suggesting that analysis of
RNA synthesis for 60 min is still within the linear range. As
observed earlier (Fig. 2), RNA accumulation by R386A was
significantly lower than that of 21 throughout the time
course. D225A, on the other hand, showed less RNA synthesis
FIG. 2. Prototype and mutant proteins used to characterize the HCV RdRp activities and an initial survey of the effects of the mutations. The
activities of 21 and mutant proteins affected in the residues identified by Bressanelli et al. (3) to bind NTP. Names of the proteins used in the
reactions are underlined at the top of the autoradiograms. The presence or absence of Mn2 at 1 mM and GTP at 200 M are indicated by plus
and minus signs, respectively. The size of each band (in nucleotides) is noted to the left of the autoradiograms.
12210 RANJITH-KUMAR ET AL. J. VIROL.
within the first 15 min of the reaction than 21 but accumu-
lated higher levels of 19-nt product upon longer incubation.
This suggests that D225A cannot form a stable productive
initiation complex to the same extent as 21, but it is capable
of efficient elongation and reinitiation.
To further confirm that the mutations affected de novo ini-
tiation, we determined whether there is an effect on the Km for
the GTPi. LE19 is designed where GTP is used only as the
initiation nucleotide and, hence, the Km value will not affect a
requirement during elongative RNA synthesis. Kinetic analysis
was done with the addition of 0.5 mg of heparin/ml at 10 min
after the start of the reaction to prevent reinitiation of RNA
synthesis and, hence, would represent the actual Km for GTP.
21 had a Km for GTP of 3.3 M (Fig. 3C), a value consistent
with the one reported by Ranjith-Kumar et al. (25). All the
mutant proteins tested, except S367A, showed higher Km val-
ues, ranging from 9 to 26 M (Fig. 3C). The majority of the
mutated residues are, therefore, involved in productive ternary
complex formation with GTP and RNA.
Specificity for the T1 nucleotide. De novo initiation requires
specific interaction with the template initiation nucleotide, T1,
and the NTPi. We examined whether mutations in the NTPi-
binding site affected specific recognition of the T1 by compar-
ing the amount of product from LE19 to that of a version of
LE19 in which the 3-most C was changed to a U (Table 1).
The HCV RdRp has been reported to initiate RNA synthesis
FIG. 3. Analysis of de novo initiation by 21 and its mutant derivatives. (A) Effect of 21 and mutants on de novo RNA synthesis. The template
used was LE19P, which contains a 3-terminal puromycin that prevents nontemplated nucleotide addition to the template. The proteins used in
each reaction and the most relevant conditions are listed above the appropriate lanes in the autoradiograms. RNA synthesis resulted in a 19-nt
band, but higher molecular size bands likely resulted from nontemplated nucleotide addition to the nascent RNA. Lower molecular size bands may
have resulted from premature termination. (B) Time course of de novo RNA synthesis by 21, D225A, and R386A. (C) Determination of Km for
initiation GTP for 21 and single mutants. Representative Lineweaver-Burke double-reciprocal plot for 21 and D225A is shown on the left. All
estimations are done in duplicates except for R48A. ND, not determined.
TABLE 1. Effects of mutations on the recognition of the template
initiation nucleotide
Protein
With Mn2 Without Mn2
1C 1U 1C 1U
21 100 11 100 12
R158A 12 1 0 0
S367A 88 8 50 15
R386A 75 8 0 0
R394A 53 5 0 0
R48A 59 1 0 0
D225A 205 1 0 0
R158A/R386A 0 0 0 0
R158A/R394A 0 0 0 0
R158A/S367A/R386A 0 0 0 0
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from a T1 uridylate at a low rate (23), and the HCV-N replicon
may even switch to using an initiation uridylate preferentially
(27). In the absence of Mn2, the only mutant that retained
RNA synthesis was S367A. Like 21, S367A clearly preferred
a T1 cytidylate for de novo initiation, because both proteins
had a reduced rate of synthesis from LE19  1U. In the
presence of Mn2, while RNA synthesis was recovered from
LE19, there was no increased preference to initiate from a T1
uridylate. Mutant D225A, which had increased de novo initi-
ation in the presence of Mn2, was also unable to initiate
efficiently from a T1 uridylate. These results indicate that the
mutations affecting the NTPi pocket do not apparently de-
crease the specificity for the T1 site.
Use of NTPi analogs. Several GTP analogs can substitute for
the NTPi in vitro (23). We examined the use of GTP analogs,
including dGTP, GDP, GMP, and guanosine, to determine
whether changes in the NTPi-binding site will affect the rec-
ognition of the NTPi (Table 2). Because LE19 contains only a
single cytidylate at the T1 position, the analogs should be
incorporated only as the 5-most residue of the newly synthe-
sized RNA and therefore would affect de novo initiation. In
the absence of Mn2, 21 and mutant S367A were capable of
initiating RNA synthesis with GDP and GMP but not with
guanosine or dGTP. The other mutant proteins were unable to
direct de novo initiation in the absence of Mn2 (Table 2), and
the substitution of GTP with analogs did not rescue de novo
initiation.
The presence of Mn2 altered the use of the GTP analogs by
both 21 and the mutant proteins. With 21, for example,
dGTP was used to initiate RNA synthesis in the presence of
Mn2. In addition, reactions with Mn2 produced more de
novo initiation products with GDP and GMP than with GTP
(Table 2) (23). We observed a range of activities with the NTPi
mutants. R386A, R394A, S367A, and R48A had activity pro-
files generally similar to that of 21, with some minor differ-
ences in the use of guanosine (R386A and R394A used it more
efficiently than 21) and GMP (R48A initiated with GMP less
efficiently than 21) (Table 2). R158A was unable to efficiently
initiate synthesis with any of the analogs and did not exhibit
preferential initiation with GDP and GMP. Interestingly,
D225A initiated with dGTP less efficiently than GTP even in
the presence of Mn2, and it did not preferentially initiate with
GDP and GMP. In this regard, D225A appeared to more
specifically require GTP as the NTPi than did 21. Small
differences in the amount of products initiated with GTP an-
alogs in this work and results reported earlier (23) may be due
to the source of NS5B protein (HCV strain J4 was used in the
previous study while BK was used in this one).
The HCV RdRp can also use short oligonucleotides as sub-
stitutes for the NTPi, as long as the oligonucleotides are able
to maintain correct base pairing with the T1 nucleotide and the
adjacent template sequence (23). We used these oligonucleo-
tides to examine whether the increased base pairing stability
between NTPi and the template can overcome the mutation-
associated effects. In the absence of Mn2, the amount of the
de novo-initiated products synthesized increased with the
length of the oligonucleotide (Table 2). Relative to GTP, GU
and pentamer GUAUA synthesized 25- and 66-fold more
product. Mutant protein R158A was unable to use either GU
or GUAUA to initiate synthesis in the absence of Mn2. Mu-
tant S367A had activities quite similar to those of 21, consis-
tent with results with single-nucleotide GTP analogs. Other
mutant proteins also had notable differences from 21. R386A
and R394A produced more of the 19 mer with GU in place of
GTP, but they were unable to use GUAUA as efficiently as
21. Mutants D225A and R48A, which were unable to initiate
with GTP in the absence of Mn2, could use GUAUA, but not
GU, for product synthesis.
In the presence of Mn2, 21 still preferred GU to GTP for
initiation (by approximately fivefold), but it produced a com-
parable amount of the product using GTP and GUAUA. This
phenomenon may be related to the conformational change
that results as a consequence of divalent metal binding to the
active site of the HCV RdRp (2, 25), which could make the
NTPi pocket more spatially constrained. The differential use of
GU and GUAUA was seen with mutants R386A, R394A, and
S367A but was less obvious with R158A, D225A, and R48A.
All of the analyses with the single and oligonucleotide NTPi
analogs confirm our hypothesis that these mutations affected
the recognition of the NTPi. Furthermore, the differential use
of NTPi mimics suggests that the mutations affect different
steps in de novo-initiated RNA synthesis. More specifically,
R386 and R394 are required for the formation of the first
phosphodiester bond, because their defects could be rescued
with the dinucleotide GU while the defects in R48A and
D225A are rescued only after the nascent RNA is 5 nt long.
TNTase activity. HCV RdRp can add nontemplated nucle-
otides to LE19 (22). This activity is difficult to distinguish
relative to template-dependent RNA synthesis in solution-
based assays (13). For 21, TNTase activity was detectable in
reactions with or without Mn2 but was more abundant in its
presence (Fig. 4) (22). Furthermore, TNTase activity was at
TABLE 2. Effect of mutation in the catalytic pocket of 21 on the incorporation of NTPi analogs
Protein
Without Mn2 With Mn2
GTP dGTP GDP GMP G GU GUAUA GTP dGTP GDP GMP G GU GUAU
21 100 5 62 139 6 2,480 6,630 100 90 288 306 48 537 102
R158A 0 0 0 0 0 1 13 18 3 19 5 0 144 154
S367A 51 1 30 68 1 978 5,751 85 98 292 285 25 381 71
R386A 0 0 0 0 0 5,207 444 68 2 175 160 139 1,044 39
R394A 0 0 0 0 0 2,253 226 51 6 283 399 125 767 32
R48A 0 0 0 0 0 0 1,140 60 12 150 66 3 349 250
D225A 0 0 0 0 0 0 2,810 272 26 226 198 8 755 480
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approximately 150% the amount of nascent RNA synthesis
with LE19. It is unclear whether the TNTase activity uses the
NTPi pocket, the I  1 pocket, or both. To examine this, we
tested the effects of mutations on the NTPi site on TNTase
activity. In the absence of Mn2, TNTase activity by the HCV
RdRp was readily detectable. Of all of the mutants, only
S367A (having 85% de novo initiation activity versus that of
21) retained TNTase activity at 30% of 21. Furthermore, for
all other single mutants, the requirements for de novo initia-
tion, TNTase activity, was restored in the presence of Mn2
(Fig. 4). These results suggest that the residues in the HCV
RdRp that are involved in de novo initiation are also involved
in TNTase activity. However, mutants R48A and D225A re-
tained robust TNTase activity but were significantly decreased
for de novo initiation in the absence of Mn2. These results
indicate that the NTPi-binding residues are required for
TNTase activity, but the requirements for the two activities do
not completely overlap.
Template switch. Several of the mutations in the NTPi
pocket affected template switch (Fig. 2). A defect in the tem-
plate switch (generating a 38 mer) is to be expected with many
of the NTPi mutants, because fewer ternary complexes are
available. However, mutant D225A, which was quite robust for
de novo initiation of the 19-nt product, produced only 14% of
the 38-nt recombinant product compared to that of 21 (Fig.
2). A double mutant R222A/D225A also showed a similar
property (Fig. 5A), while mutant R222A behaved like the wild
type for de novo initiation and template switch (data not
shown). To examine this further, we made mutant D225Y and
found that it also had reduced template switch activity (Fig.
5A, lanes 9 to 12). We hypothesize that D225, which recognizes
the ribose 3 hydroxyl of the NTPi, also plays an additional role
FIG. 4. Examination of nontemplated nucleotide addition to the template RNA. The names of the proteins used and the most relevant
conditions are indicated above the appropriate lanes in the autoradiogram. The term rCr3 means that the reaction contains all four nucleotides,
with CTP being the radiolabel. rC denotes a reaction performed with only [-32P]CTP. The lengths of the products, in nucleotides, are indicated
to the left of the autoradiogram. All of the lanes within a panel are from one experiment, but some lanes are juxtaposed to facilitate presentation
of the results.
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either in recognition of the second template or in the release of
the nascent RNA.
To characterize the role of D225A further, we used template
14-2, which has been demonstrated to give a high level of
template switch with the HCV RdRp (16). The ratios of mul-
timeric products formed relative to monomer by 21 and
D225A at three different template concentrations were quan-
tified. The reactions were performed in the presence of Mn2
to increase the frequency of template switch, and the results
were normalized for the number of radiolabeled CMP incor-
porated. The frequency of template switch events by D225A
was more than fivefold lower than that of 21 at all template
concentrations tested (Fig. 5B). Taken together, these data
support a model where multiple RdRp conformational inter-
mediates are formed during RNA synthesis, with residue D225
being involved in these functions.
Ribavirin and HCV RNA synthesis. A medically relevant
aspect of NTP use by the HCV RdRp is the incorporation of
ribavirin, which is used in combination with interferon to
treat HCV infection (10–12, 20). Ribavirin is incorporated
in place of purine triphosphates and may result in an in-
creased error rate in the newly synthesized RNAs, leading to
a loss of virus infectivity (9, 19). Ribavirin incorporation was
reported to involve residue Y415 of the HCV RdRp, which
is a residue that lines the template-binding pocket of the
HCV RdRp (28). We sought to determine whether incor-
poration of ribavirin triphosphate (RTP) requires the resi-
dues of the NTPi pocket.
We first determined whether the HCV RdRp could incor-
porate RTP into product RNAs by using template LE19. In
reactions with only ATP, CTP, and UTP (each at 100 M final
concentration), no de novo initiation was observed due to the
absence of GTP (Fig. 6A, lanes 2 and 12). Increasing RTP in
the reactions up to 500 M did not result in further production
of the 19 mer either in the presence or absence of Mn2 (Fig.
6A, lanes 3 to 6 and 13 to 16), indicating that RTP cannot
functionally substitute for the NTPi. Similar results were ob-
tained with LE19P, confirming that RTP was unable to initiate
RNA synthesis (Fig. 6B). However, we note that the 32-nt
primer extension product and the 20- and 21-nt TNTase prod-
ucts were quite prominent in these reactions and that increas-
ing ribavirin did not significantly inhibit their production unless
Mn2 was present in the reactions (Fig. 6A). These results
indicate that ribavirin is incorporated poorly in the presence of
ATP, CTP, and UTP during primer extension and terminal
nucleotide addition.
We attempted to incorporate ribavirin in reactions lacking
both GTP and ATP. Increasing RTP resulted in production of
the 32-nt primer extension product, possibly indicating that
RTP was inefficiently incorporated into the newly synthesized
RNA in place of ATP (Fig. 6A, lanes 17 to 20). Because GTP
is not necessary for the synthesis of the 32-nt elongation prod-
uct, we were unable to test whether RTP could substitute for
GTP during elongation with LE19. Interestingly, incorporation
of RMP was slightly higher in the absence of Mn2 (Fig. 6A,
lanes 7 to 10).
Because RTP could not substitute for the initiating GTP, we
determined whether it would inhibit de novo initiation with
LE19P when the full complement of NTPs was present. In the
absence of Mn2 there was an inhibitory effect of ribavirin,
with the 50% inhibitory concentration being approximately 400
M. In the presence of Mn2, where there was robust de novo
initiation, the effect of up to 1 mM RTP was minimal, with a
decrease to only 15% relative to that of a reaction lacking
RTP. Any role of ribavirin on de novo-initiated RNA synthesis
thus appeared to be indirect.
We also tested whether any of the catalytic mutants are
affected in RTP incorporation during RNA synthesis. Incor-
poration of RTP was not significantly different for any of the
mutants compared to that of 21 (data not shown). These
results show that perturbations of the catalytic site in the HCV
RdRp do not necessarily increase the incorporation of ribavi-
rin triphosphate.
DISCUSSION
Cocrystallization of the HCV RdRp with NTP identified a
number of contacting residues in the RdRp (Fig. 1A) (3). To
functionally analyze the role of these amino acids, we gener-
ated several alanine substitution mutants and analyzed their
biochemical activities. A change of S367, which putatively hy-
FIG. 5. Production of template switch products by mutant D225.
(A) Autoradiogram of the products made by 21 and mutant R222A/
D225A and D225Y. The relevant conditions for the reactions are
indicated above the autoradiogram. (B) Quantification of the oligo-
meric products made by 21 and D225A using three concentrations of
template 14-2 (12.5, 62.5, and 125 nM represented as 1-, 5-, and 10-,
respectively), which was previously characterized for template switch
(16). The amounts of the products made were normalized for the
amount of radiolabeled CMP incorporated and plotted as ratio of
monomer to template switch products.
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drogen bonds with the  phosphate of the GTP, had no obvi-
ous effect on the activities we tested. The remainder of the
Discussion will deal with observations for the other residues
(R48, R158, R386, R394, and D225). First, we present evi-
dence that the residues interact with the NTPi, because alanine
substitutions in them (i) preferentially affected de novo initia-
tion rather than primer extension; (ii) increased the Km for the
NTPi during de novo initiation; (iii) had defects that could be
overcome with Mn2, which likely interacts with the phos-
phates and helps to neutralize their charges, thereby amelio-
rating the impact of some mutations in the RdRp; and (iv)
could be partially overcome by replacing the GTP with NTPi
analogs. We note, however, that despite the effects on inter-
action with the NTPi, the mutations did not make the HCV
RdRp less specific in the use of the NTPi, because the mutants
still preferred  1C for initiation and all of the analogs used
possessed a guanine (Tables 1 and 2). Mutational analysis of
the NTPi residues also revealed that the different activities of
the HCV RdRp could be functionally separated into de novo
initiation, primer extension, TNTase activity, and template
switch (Table 3). Again, Mn2 plays an active role in these
activities, and its presence can ameliorate the effects of some
FIG. 6. RNA synthesis by the HCV RdRp in the presence of ribavirin triphosphate. (A) Autoradiogram of the products made by 21 under
different reaction conditions. RTP was added to reactions lacking either GTP or both GTP and ATP, as indicated by the notations G and
G,A. The 32-nt product in lanes 17 to 20 demonstrates that RTP was incorporated during elongative synthesis in place of ATP. (B) An assay
to confirm that RTP cannot serve as the initiation NTP. The assay used the puromycin-modified LE19P. The control reactions are indicated by
G. (C) Examination of whether RTP inhibits RNA synthesis by the HCV RdRp in reactions containing all of the normal NTPs. The level of
synthesis was quantified and normalized to one lacking RTP.
TABLE 3. Summary of the activities of the mutations tested with RNA LE19 in this studya
Protein
Without Mn2 With Mn2
Primer
extension
Template
switch
De novo
initiation TNTase
Primer
extension
Template
switch
De novo
initiation TNTase
21        
S367A        
R158A        
R386A        
R394A        
R48A        
D225A        
a , high level of activity; , detectable; , not detected.
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mutations. The effects of some of the mutant proteins revealed
interesting relationships, as will be discussed below.
Relationships between biochemical activities. Some muta-
tions affect more than one biochemical activity. A summary of
how the mutations affected the activities examined is provided
in Table 3. D225 is required for de novo initiation (both in
terms of the synthesis of the 19 mer and in mediating the
GTP-induced repression of primer extension) and in the ability
to switch templates. Previously it was determined that template
switch was also more efficient when the second template had
an initiation cytidylate, suggesting that template switch shared
requirements for de novo initiation (16). One model to explain
the dual role of the de novo residues is that multiple confor-
mations of the RdRp are associated with RNA synthesis. Dur-
ing initiation, the polymerase must bind two NTPs, but after
the formation of the first phosphodiester bond the residues
that are required to bind the NTPi may be used for other
activities.
In general, mutations that affected de novo initiation also
affected TNTase activity. Except for R48A and D225A, muta-
tions that caused the loss of de novo synthesis in the absence of
Mn2 were also unable to add nontemplated nucleotide (Fig.
4). Consistent with this claim, the presence of Mn2 increased
both de novo initiation and nontemplated nucleotide addition
(Fig. 2). These results suggest that the NTPi-binding pocket
may also be required for TNTase activity, either by providing
the NTP for the TNTase activity or allowing a more stable
interaction with the template RNA to facilitate nontemplated
nucleotide addition. We favor the latter model for the follow-
ing reasons. First, mutational analysis of the NTPi site shows
that the requirements for the two activities are not completely
overlapping. Second, the NTPi pocket is highly specific for
GTP and GTP analogs, while TNTase activity prefers to add
ATP and CTP (22). Third, we could functionally separate the
two activities in the presence of 100 mM NaCl (22). In
addition, several mutations affecting the NTPi pocket also ex-
hibited defects in template switch, suggesting that the defect in
template interaction may be the reason behind effects on sev-
eral activities.
Recognition of the NTPi. It was observed in a previous work
that the use of the NTPi was highly specific (23). In this work,
we demonstrated that changes in the RdRp did not increase
the range of the NTPi molecules that can be incorporated.
Ribavirin triphosphate, a purine nucleotide analog, was not
recognized as the NTPi. We have observed that ribavirin can
be incorporated during elongative synthesis when ATP con-
centration is low (data not shown), demonstrating that it is
incorporated only after binding to the 1 1 site. The use of the
GTP analogs and the discrimination against RTP suggest that
recognition of the NTPi is not dependent on Watson-Crick
interactions with the template. The T7 RNA-dependent RNA
polymerase also recognizes the NTPi in a base-specific manner
(17). Because recognition of the NTPi is not needed in poly-
merases that extend from a primer, it is likely a unique prop-
erty of de novo-initiating polymerases. The identities of the
residues that interact with the guanine base in the HCV RdRp
need to be determined.
Another aspect in the recognition of the NTPi is the require-
ment for the ribose sugar. The HCV RdRp appears to discrim-
inate against use of dGTP by forming an H bond with the
ribose 2 hydroxyl. Unlike the base requirements, recognition
of the ribose is not absolutely required, because dGTP can still
direct initiation when Mn2 is present in the reaction. Fur-
thermore, mutant D225A could initiate RNA synthesis de
novo in the presence of Mn2. However, when changed to a
tyrosine, de novo initiation was severely reduced (Fig. 5A).
These results indicate that a bulky tyrosine group at position
225 is incompatible for RNA synthesis. We have not been able
to detect incorporation of dNTPs efficiently by the HCV RdRp
variants, including D225A and D225Y, except as the NTPi
(C. T. Ranjith-Kumar, unpublished observations). In other
polymerases, mutations that expand the use of the nucleotides
affected the recognition of the N  1 nucleotide, not the NTPi.
We would expect that the recognition of the riboses of the two
nucleotides should have different requirements (4, 5).
Several lines of evidence suggest that the mutations affect
the stability of the initiation complex. One potential contribu-
tor to the stability may be Mn2, whose presence rescued a
number of activities (Table 3). Mn2-dependent activity was
also observed with poliovirus RdRp in cells (8), indicating that
even though it is present in only micromolar concentrations, it
should not be ruled out as a possible RdRp cofactor, because
the HCV RdRp may have higher affinity for Mn2 than for
Mg2. In addition, mutants R386A and R394A, which were
incapable of RNA synthesis with GTP in the absence of Mn2,
were capable of efficient RNA synthesis with GU (Table 2).
Also, D225A and R48A, which could not use GTP and GU in
the absence of Mn2, were capable of robust RNA synthesis
with GUAUA, a GTPi analog that could form more stable
base pairing with the template. This suggests that the catalytic
mutants have a differential effect on RNA synthesis, with R386
and R394 being required for the formation of the first phos-
phodiester bond formation. Mutants R48A and D225A, how-
ever, may require additional forces to stabilize the initiation in
order to successfully produce RNA products.
Recently, the crystal structure of bovine viral diarrhea virus
RdRp in complex with GTP was determined, with assigned i
and i  1 sites (7). This complex did not contain divalent
metals that, in the HCV RdRp, caused a detectable confor-
mational change (25). Perhaps due to the lack of divalents, the
GTP molecule in complex with the BVDV was 6 A˚ from the
expected site. Nonetheless, several residues that interacted
with this GTP and with the initiating NTPs corresponded to
the ones that are seen with the HCV RdRp. More specifically,
residues S498, R517, D350, and R285 correspond, respectively,
to residues S367, R386, D225, and R158 in HCV RdRp. S498
and D350 were shown previously to be necessary for RNA
synthesis (28).
In summary, our functional characterization of the effects of
mutations in the NTPi pocket revealed a complex relationship
between several of the RdRp-associated activities in vitro.
Given that de novo initiation is likely used for HCV RNA
replication in cells, we suspect that similar mutations will pre-
vent HCV replication in vivo by disrupting one or more activ-
ities. Results consistent with this were presented by Cheney et
al. (6), who showed that residues that negatively affected RNA
synthesis in vitro debilitated HCV replication in a subgenomic
replicon. Lastly, the availability of variants of the HCV RdRp
that are differentially defective for specific activities will be
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useful for further dissection of the mechanism of RNA-depen-
dent RNA synthesis.
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